Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
Journal of Gastric Cancer|October 19, 2016
Efficacy and Safety of Bolus 5-Fluorouracil and L-Leucovorin as Salvage Chemotherapy for Oral Fluoropyrimidine-Resistant Unresectable or Recurrent Gastric Cancer: A Single Center ExperienceTetsuhito Muranaka, Satoshi Yuki, Yoshito Komatsu, et al.
Future Oncology (London, England)|June 30, 2023
Clinical outcomes of intensive versus less intensive first-line chemotherapy for metastatic colorectal cancerKentaro Yamazaki, Satoshi Yuki, Eiji Oki, et al.
Investigational New Drugs|August 6, 2022
An open-label, crossover study to compare different formulations and evaluate effect of food on pharmacokinetics of pimitespib in patients with advanced solid tumorsYoshito Komatsu, Tsuneo Shimokawa, Kohei Akiyoshi, et al.
Journal of Cancer Research and Clinical Oncology|December 20, 2012
Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapyKohei Shitara, Satoshi Yuki, Kentaro Yamazaki, et al.
Clinical Colorectal Cancer|January 1, 2021
Prognostic Value and Molecular Landscape of HER2 Low-Expressing Metastatic Colorectal CancerMasataka Yagisawa, Kentaro Sawada, Yoshiaki Nakamura, et al.
The Oncologist|June 21, 2019
One-Day Versus Three-Day Dexamethasone in Combination with Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Individual Patient Data-Based Meta-AnalysisYuki Okada, Koji Oba, Naoto Furukawa, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 12, 2019
Evaluation of Risk Factors for Major Amputation in Patients With Diabetes and Peripheral Artery Disease Receiving Antiplatelet Therapy　- Post Hoc Analysis of a Prospective Observational Multicenter Cohort Study (SEASON)Yukihito Higashi, Tetsuro Miyata, Hiroshi Shigematsu, et al.
Investigational New Drugs|December 17, 2013
Phase 1 study of efatutazone, a novel oral peroxisome proliferator-activated receptor gamma agonist, in combination with FOLFIRI as second-line therapy in patients with metastatic colorectal cancerYoshito Komatsu, Takayuki Yoshino, Kentaro Yamazaki, et al.
Future Oncology (London, England)|July 17, 2023
The BEETS (JACCRO CC-18) trial: an observational and translational study of <i>BRAF</i>-mutated metastatic colorectal cancerChiaki Inagaki, Ryo Matoba, Satoshi Yuki, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2008
5-Aryl-imidazolin-2-ones as a scaffold for potent antioxidant and memory-improving activityKazutoshi Watanabe, Yasuhiro Morinaka, Yoshio Hayashi, et al.
Pageof 12